Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.
Thomas J MoorePhillip W WirtzJill N CurranG Caleb AlexanderPublished in: BMJ open (2023)
A large proportion of adults using Schedule II stimulants are simultaneously exposed to one or more other CNS-active drugs, many with tolerance, withdrawal effects or potential for non-medical use. There are no approved indications and limited clinical trial testing of these multi-drug combinations, and discontinuation may be challenging.